Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylitol wipes for infection reduction in SCT patients
NCT04117477Phase 2Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of xylitol in Bacteremia, gingivitis, dental plaque, oral ulceration, sponsored by Cincinnati Children's Hospital Medical Center. Started Sep 2019; status: terminated.
02
Drugs
xylitol
03
Conditions
Bacteremiagingivitisdental plaqueoral ulceration
Beyond the preview
Go deeper on NCT04117477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117477.